Study Details

General Information

Abbott Schizophrenia 765 Ext

Phase 2, Partial-Blind, Multi-Center Extension Study to Evaluate the Long-Term Safety and Health Outcomes of ABT-126 in Subjects who Completed Study M10-855

ProtocolM13-765
IdentifierM13-765 Site Number 26 PO Number 4200025336
UID7d76215b-e032-4bec-a5f9-00e473cf2580
StatusDone - Archived
Phase2
CategorySchizophrenia / Adult
Launch Year2013
NCT Number-
Created2013-02-25 10:58
Last Updated2013-02-25 10:58

Description

No description provided.

Comment

No comment.

Target Dates

NameDateRequired
Enrollment ClosedNo
Enrollment OpenNo
First Patient First VisitNo
Site Initiation Mtg.2013-05-23No
PI Meeting StartNo
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout Date2015-01-20No
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalMartinez, GilbertGJMartinezNo
Recruiter-No
CoordinatorBarnett, OmarOBarnettNo
Regulatory-No

Custom Fields

No custom fields.

Sponsor & Organization

SponsorAbbVie
DivisionAbbVie
TeamAbbott
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref
CRO
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorGainsboro
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?